Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Trial of Two Regimens of Misoprostol for Second Trimester Termination for Intrauterine Fetal Death

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 14 and 24 weeks of gestation~* Both nulliparous and multiparous women~* An unfavorable cervix (Bishop's score less than 8)~Exclusion Criteria:~* Known contraindications to the use of prostaglandins (e.g. asthma)~* Previous uterine scar (previous cesarean or myomectomy where the endometrial cavity was entered)

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- A (Type: ACTIVE_COMPARATOR): Vaginal Cytotec at doses of 400 microgram every 4 hours until delivery
- B (Type: ACTIVE_COMPARATOR): Sublingual Cytotec at doses of 400 microgram every 4 hours until delivery

Based on this trial design, predict the completion outcome and termination type (if applicable).